A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in combination with docetaxel in patients with advanced solid tumours
Titel:
A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in combination with docetaxel in patients with advanced solid tumours
Auteur:
Soria, Jean Charles Massard, Christophe Lazar, Vladimir Ozoux, Marie-Laure Mery-Mignard, Dominique Deslandes, Antoine Tolcher, Anthony W.